Activity-Dependent Modulation of Tonic GABA Currents by Endocannabinoids in Hirudo verbana
Basic science published in Front Synaptic Neurosci (2022)
Abstract
Endocannabinoids are lipid neuromodulators that are synthesized on demand and primarily signal in a retrograde manner to elicit depression of excitatory and inhibitory synapses. Despite the considerable interest in their potential analgesic effects, there is evidence that endocannabinoids can have both pro-nociceptive and anti-nociceptive effects. The mechanisms contributing to the opposing effects of endocannabinoids in nociception need to be better understood before cannabinoid-based therapies can be effectively utilized to treat pain. Using the medicinal leech, Hirudo verbana, this work investigates whether endocannabinoids modulate tonic inhibition onto non-nociceptive afferents. In voltage clamp recordings, we analyzed changes in the tonic inhibition in pressure-sensitive (P) cells following pre-treatment with endocannabinoids, 2-arachidonoylglycerol (2-AG) or anandamide (AEA). We also tested whether high frequency stimulation (HFS) of nociceptive (N) cells could also modulate tonic inhibition. Both endocannabinoid application and N cell HFS depressed tonic inhibition in the P cell. Depression of tonic inhibition by N cell HFS was blocked by SB 366791 (a TRPV1 inhibitor). SB 366791 also prevented 2-AG-and AEA-induced depression of tonic inhibition. HFS-induced depression was not blocked by tetrahydrolipstatin (THL), which prevents 2-AG synthesis, nor AM 251 (a CB1 receptor inverse agonist). These results illustrate a novel activity-dependent modulation of tonic GABA currents that is mediated by endocannabinoid signaling and is likely to play an important role in sensitization of non-nociceptive afferent pathways.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Endocannabinoids 2-AG and anandamide depress tonic GABA inhibition in Hirudo verbana pressure-sensitive cells via TRPV1, providing a model for nociceptive sensitization mediated by endocannabinoids.
Por qué esto importa para la hirudoterapia
Este estudio empleó la sanguijuela medicinal Hirudo verbana para investigar si los endocannabinoides modulan la inhibición tónica de GABA sobre aferencias no nociceptivas, hallando que tanto los endocannabinoides aplicados exógenamente (2-AG y AEA) como la estimulación de alta frecuencia de neuronas nociceptivas deprimieron la inhibición tónica en células sensibles a la presión. La depresión fue bloqueada por el inhibidor de TRPV1 SB 366791 pero no por inhibidores de la síntesis de 2-AG ni por agonistas inversos del receptor CB1, lo que sugiere una vía novedosa de modulación endocannabinoide dependiente de actividad relevante para la sensibilización de aferencias no nociceptivas. Este trabajo es relevante para el dominio de la ASH porque aprovecha el sistema nervioso de la sanguijuela medicinal como modelo para estudiar los mecanismos neuromoduladores de la nocicepción. El estudio es neurociencia básica pura sin investigación de aplicaciones terapéuticas, del secretoma de la sanguijuela ni de hirudoterapia.
Citación
Activity-Dependent Modulation of Tonic GABA Currents by Endocannabinoids in Hirudo verbana.
Paulsen RT, Burrell BD · Frontiers in synaptic neuroscience, 2022
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026